Hereditary spherocytosis

MONDO:0019350

Hereditary spherocytosis is a congenital hemolytic anemia with a wide clinical spectrum (from symptom-free carriers to severe hemolysis) characterized by anemia, variable jaundice, splenomegaly and cholelithiasis.

Also known as: Minkowski-Chauffard disease, congenital spherocytic hemolytic anaemia, hereditary spherocytosis, spherocytic anaemia, congenital spherocytosis

11 clinical trials for this condition and its sub-types, 2 tagged with Hereditary spherocytosis itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Familial hemolytic anemia (27)

Sub-types of Hereditary spherocytosis

Hereditary spherocytosis type 1 0 trials
Hereditary spherocytosis type 2 0 trials
Hereditary spherocytosis type 3 0 trials
Hereditary spherocytosis type 4 0 trials
Hereditary spherocytosis type 5 0 trials

Including sub-types (11) Tagged with Hereditary spherocytosis (2)

Trials to join now! 6 Not yet recruiting 2 Not yet finished but already full! 1 Completed 2

New blood treatment could block zika in transfusions

Disease control Ongoing

This study tests a special treatment for red blood cells that aims to kill the Zika virus, making transfusions safer. About 692 people who need blood transfusions will receive either treated or standard blood. The goal is to see if the treated blood works just as well and is safe…

Phase 3 • Sponsor: Cerus Corporation • Aim: Disease control

Last updated Jun 27, 2026 11:03 UTC

Hereditary spherocytosis

Where it sits in the disease tree

New blood treatment could block zika in transfusions